The mechanism of action may involve reducing the level of drug resistance related factors MDR1/P-gp, NF-κB/IκB, blocking mitosis, promoting tumor cell apoptosis, inhibiting angiogenesis and lymphatic vessel formation and inhibiting COX-2 expression (12). This evidence concerns the gene PGP and neoplasm.